Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder

Summary

The purpose of this study is to determine whether increasing the amount (dose) of quetiapine IR (immediate release formulation) more rapidly than conventional dose increases, improves the control of symptoms as measured by the Positive and Negative Syndrome Scale (PANSS) - a psychiatric assessment scale that measures both positive and negative symptoms - in patients with acute schizophrenia or schizoaffective disorder.

Timeline

Start

2007-07

Primary completion

—

Completion

2007-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study terminated due to poor recruitment”

Drugs

Indications